Ally Bridge Group (Ny) LLC Leap Therapeutics, Inc. Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.6 - $3.35 $2.9 Million - $6.08 Million
-1,815,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.08 - $3.65 $1.28 Million - $2.24 Million
615,000 Added 51.25%
1,815,000 $5.88 Million
Q3 2021

Nov 15, 2021
BUY
$1.35 - $4.01 $1.62 Million - $4.81 Million
1,200,000 New
1,200,000 $4.81 Million

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $286M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email